創新藥物

創新藥板塊聚焦原創藥物從靶點發現到臨床轉化與商業化全鏈條。核心賽道涵蓋小分子、單抗/雙抗與ADC、細胞與基因治療、核酸藥物及CRO/CMO。該板塊總市值為 1797.77 billion HKD,24h 漲跌幅 -0.46%,40 檔中,16 檔上漲 (40.00%),23 檔下跌 (57.50%)。領漲個股為 樂普生物-B (02157),24h 漲幅為 +3.37%。創新藥企在資金湧入龍頭股的情況下走向盤整,小型股出現分化。短期內以交易研發管線名列前茅的個股為主;中期則可在臨床試驗里程碑與政策/利率訊號出現時加碼。
名稱
最新價
漲跌幅
最新價 / 漲跌幅
走勢圖
價格區間
操作
01801
信達生物-B01801
HK$89.90$370.61
+0.61%+$2.26
HK$89.90
+0.61%
$363.80$370.81
06160
百濟神州06160
HK$195.3$805.1
-2.20%-$18.1
HK$195.3
-2.20%
$798.1$826.1
01093
石藥集團01093
HK$8.49$34.99
+2.28%+$0.78
HK$8.49
+2.28%
$34.21$35.53
02269
藥明生物02269
HK$38.58$159.04
-0.20%-$0.32
HK$38.58
-0.20%
$157.47$160.03
02359
藥明康德02359
HK$156.6$645.5
-0.25%-$1.6
HK$156.6
-0.25%
$642.2$649.7
01548
金斯瑞生物科技01548
HK$16.81$69.29
-0.05%-$0.04
HK$16.81
-0.05%
$68.26$69.58
02162
康諾亞-B02162
HK$78.05$321.76
-5.16%-$17.52
HK$78.05
-5.16%
$318.87$342.16
09926
康方生物09926
HK$96.00$395.75
-2.63%-$10.71
HK$96.00
-2.63%
$392.04$408.33
02228
晶泰控股02228
HK$7.12$29.35
-0.69%-$0.20
HK$7.12
-0.69%
$28.23$29.59
01530
三生製藥01530
HK$17.14$70.65
+0.05%+$0.04
HK$17.14
+0.05%
$69.79$70.70
02268
藥明合聯02268
HK$53.90$222.20
-0.82%-$1.85
HK$53.90
-0.82%
$217.04$225.08
01177
中國生物製藥01177
HK$5.09$20.98
0.00%$0.00
HK$5.09
0.00%
$20.73$21.02
06990
科倫博泰生物-B06990
HK$508.5$2,096.2
-0.97%-$20.6
HK$508.5
-0.97%
$2,061.2$2,116.8
09995
榮昌生物09995
HK$84.75$349.38
-1.05%-$3.71
HK$84.75
-1.05%
$343.40$354.12
03692
翰森製藥03692
HK$32.32$133.23
+0.06%+$0.08
HK$32.32
+0.06%
$132.33$134.80
02367
巨子生物02367
HK$28.90$119.13
-0.48%-$0.57
HK$28.90
-0.48%
$117.49$122.35
01276
恒瑞醫藥01276
HK$57.60$237.45
+0.96%+$2.26
HK$57.60
+0.96%
$234.36$237.86
00867
康哲藥業00867
HK$12.14$50.04
+0.99%+$0.49
HK$12.14
+0.99%
$49.05$50.08
02157
樂普生物-B02157
HK$4.59$18.92
+3.37%+$0.61
HK$4.59
+3.37%
$18.18$19.70
02096
先聲藥業02096
HK$12.81$52.80
+1.50%+$0.78
HK$12.81
+1.50%
$51.94$52.80